New Leaf Venture Partners’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,859,168
| Closed | -$21.1M | – | 12 |
|
|
2023
Q4 | $21.1M | Buy |
1,859,168
+1,543,500
| +489% | +$12.1M | 17.03% | 2 |
|
|
2023
Q3 | $1.27M | Sell |
315,668
-2
| -0% | -$15 | 1.63% | 10 |
|
|
2023
Q2 | $2.24M | Hold |
315,670
| – | – | 1.92% | 10 |
|
|
2023
Q1 | $2.34M | Hold |
315,670
| – | – | 1.93% | 9 |
|
|
2022
Q4 | $2.29M | Hold |
315,670
| – | – | 1.66% | 12 |
|
|
2022
Q3 | $3.06M | Hold |
315,670
| – | – | 1.82% | 10 |
|
|
2022
Q2 | $6.03M | Hold |
315,670
| – | – | 3.91% | 7 |
|
|
2022
Q1 | $15.7M | Hold |
315,670
| – | – | 7.73% | 3 |
|
|
2021
Q4 | $23.8M | Hold |
315,670
| – | – | 8.63% | 2 |
|
|
2021
Q3 | $24.9M | Hold |
315,670
| – | – | 7.19% | 5 |
|
|
2021
Q2 | $3.36M | Hold |
315,670
| – | – | 0.86% | 13 |
|
|
2021
Q1 | $66M | Buy |
315,670
+23,529
| +8% | +$4.72M | 15.37% | 2 |
|
|
2020
Q4 | $48.5M | Hold |
292,141
| – | – | 11.21% | 4 |
|
|
2020
Q3 | $49.6M | Hold |
292,141
| – | – | 20% | 3 |
|
|
2020
Q2 | $48.5M | Hold |
292,141
| – | – | 13.92% | 4 |
|
|
2020
Q1 | $33.8M | Hold |
292,141
| – | – | 10.12% | 4 |
|
|
2019
Q4 | $43.2M | Hold |
292,141
| – | – | 9.39% | 5 |
|
|
2019
Q3 | $39.9M | Hold |
292,141
| – | – | 12.07% | 4 |
|
|
2019
Q2 | $38M | Hold |
292,141
| – | – | 10.18% | 4 |
|
|
2019
Q1 | $27.7M | Buy |
+292,141
| New | +$38.4M | 7.58% | 4 |
|
New Leaf Venture Partners's HARP Position: Q1 2024 in Review
New Leaf Venture Partners sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 1,859,168 shares — an estimated $21.1M sold.
New Leaf Venture Partners first reported a position in HARP in Q1 2019 and held it in 20 quarters. The position peaked at $66M in Q1 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.
- New Leaf Venture Partners reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- New Leaf Venture Partners sold 1,859,168 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $21.1M.
- New Leaf Venture Partners first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
- New Leaf Venture Partners's Harpoon Therapeutics, Inc. Common Stock position peaked at $66M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.
Based on New Leaf Venture Partners's 13F filing for Q1 2024, filed 14 May 2024.